SHAREHOLDER ALERT: WeissLaw LLP Reminds AYR, CBPX, INST, and HEMA Shareholders About Its Ongoing Investigations

NEW YORK, Jan. 14, 2020 (GLOBE NEWSWIRE) --

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY  10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Aircastle Limited (NYSE: AYR)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Aircastle Limited (NYSE: AYR) in connection with the proposed acquisition of the Company by Marubeni Corp and Mizuho Leasing Co.  Under the terms of the acquisition agreement, AYR shareholders will receive $32.00 in cash for each AYR share that they own.  If you own AYR shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/aircastle-limited/

Continental Building Products, Inc. (NYSE: CBPX)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Continental Building Products, Inc. (NYSE: CBPX) in connection with the proposed acquisition of the Company by Compagnie de Saint-Gobain S.A. (PAR: SGO) (“Saint-Gobain”).  Under the terms of the acquisition agreement, CBPX shareholders will receive $37.00 for each CBPX share that they own.  If you own CPBX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/continental-building-products-inc/

Instructure, Inc. (NYSE: INST)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Instructure, Inc. (NYSE: INST) in connection with the proposed acquisition of the Company by Thoma Bravo, LLC.  Under the terms of the acquisition agreement, INST shareholders will receive $47.60 for each INST share that they own.  If you own INST shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/instructure-inc-investigation/    

HemaCare, Inc. (OTCMKTS: HEMA)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of HemaCare, Inc. (OTCMKTS: HEMA) in connection with the proposed acquisition of the Company by Charles River Laboratories International, Inc.  Under the terms of the acquisition agreement, HEMA shareholders will receive $25.40 for each HEMA share that they own.  If you own HEMA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: http://www.weisslawllp.com/hemacare-corporation-investigation/     

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.